Pharma Tech Outlook: Pharma Tech Magazine

 Lakepharma  : The Face Of Next-Gen Drug Development

Top 10 CMOs - 2021


In the last year alone, the pharmaceutical sector has witnessed phenomenal changes. The rush for a potent vaccine in the wake of the pandemic made it imperative for organizations to bolster their capabilities and foster robust partnerships. In this background, many pharma organizations started enhancing their production by partnering with market-leading contract manufacturing organizations (CMOs). Multiple factors like tight timelines, cost-reductions, and quality standards began prompting pharma organizations to turn to CMOs. And to keep up with this evolution, CMOs are now investing in robust technologies to shore up their capabilities.

CMOs that are on the helm of digitalization are already integrating emerging technologies and unlocking the benefits or reduced costs and risks associated with drug manufacturing, while achieving unprecedented levels of efficiency and productivity for their pharma partners. Specifically, robotic process automation (RPA), AI, and machine learning are turning out to be key factors that are empowering CMOs to meet the evolving requirements of the pharmaceutical sector. Whether it is automating back-office tasks or process-oriented operations, CMOs are increasingly adopting emerging technologies to streamline their drug production processes.

To assist pharmaceutical organizations in the task of finding the most accomplished CMOs, we have compiled this issue of Pharma Tech Outlook. It is elaborately crafted to assist you in fostering productive partnerships and improving performance. In this edition, we have listed the top 10 CMOs to highlight those making significant contributions to the pharmaceutical sector. Equipped with innovative technological capabilities, these CMOs are set to transform the landscape. This edition also blends thought leadership articles from subject-matter experts and CXOs. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster a workspace driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s, “Top 10 CMOs - 2021.”

    Top CMOs

  • Provides integrated solutions ranging from discovery to engineering, development, and GMP manufacturing

  • Develops complex biologic therapeutics by being the pre-eminent provider of high-quality, cost-effective, flexible and timely cGMP compliant manufacturing solutions

  • Provides integrated solutions ranging from discovery to engineering, development, and GMP manufacturing

  • Ology Bioservices is the partner of choice for complicated biologics CDMO services with a focus on Cell & Gene Therapy

  • Almac Group

    Almac Group

    The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Our innovative services range from R&D, biomarker discovery, development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture. The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia. Click here to view our facilities

  • Catalent


    Catalent is a global leader in providing integrated services, superior delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products. We have built an advanced range of technologies and capabilities and are dedicated to enabling a better and faster customer journey from product development to patient. With over 85 years of experience, Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. We became a publicly traded company (NYSE: CTLT) in 2014 and have grown to become a vibrant community of approximately 15,500 + employees who support over 7,000 products for over 1,000 customers all around the world. At Catalent, we share a common goal: to put patients first and help people around the world live better and healthier lives.

  • Kamat Pharmatech

    Kamat Pharmatech

    Kamat Phamatech specialized in the development, manufacturing, and approval of injectable products and processes, especially in the areas of biologics and oncology

  • Lonza


    Lonza is a leading global provider of integrated healthcare solutions. We focus on enabling treatments that prevent illness, support healthier lifestyles and create a healthy environment. We optimize scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers.Today Lonza is a global leader in life sciences. We are more than 15,500 employees in more than 120 locations around the world. Together in 2019, we achieved global sales of 5.9 CHF billion. We apply our industry knowledge to pioneer cell therapy and the medicines of tomorrow. Our work enables our customers to protect millions of people from illness and disease. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together, devising commitment and ideas that help our customers to help people. In exchange, we let our people own their careers. Their ideas, big and small, genuinely improve the world. And that’s the kind of work we want to be part of.

  • Pfizer


    Pfizer is a global contract development and manufacturing organization (CDMO) embedded within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply. For more than 40 years, we've been guiding complex compounds securely and efficiently from development through commercial manufacture. Working together with our customers, we combine our knowledge with open dialogue to solve challenges. Intelligent collaboration with Pfizer CentreOne

  • Recipharm


    Recipharm is a leading contract development and manufacturing organisation (CDMO) headquartered in Stockholm, Sweden. We operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering for our customers. Employing around 9,000 people, we are focused on supporting pharmaceutical companies with our full service offering, taking products from early development through to commercial production. For over 25 years we have been there for our clients throughout the entire product lifecycle, providing pharmaceutical expertise and managing complexity, time and time again. Despite our growing global footprint, we conduct our business as we always have and continue to deliver value for money with each customer’s needs firmly at the heart of all that we do. That’s the Recipharm way